Treatment

Presentation by Victor Rosenfeld, M.D., Medical Director at Sleepmed of Santa Barbara. Provides the history of fibromyalgia; the diagnosis and classification of FMS; pathophysiology of FMS; literature review of current treatment strategies on Pregabalin, Duloxetine, Minalciprin, Tramadol & Sodium Oxybate; and Current E.U.L.A.R. recommendations.

In treating cancer, the pencil beam technology for proton therapy delivers a single, narrow proton beam (about a centimeter in diameter) that is magnetically swept across the tumor, depositing the radiation dose like a painter

An introduction to computational methods for analyzing ChIP-Seq data by Cristian Coarfa. This was presented as a lab within the Computer Aided Discovery Methods course offered within the Graduate Program at Baylor College of Medicine.

Daniele Piomelli, PhD. - Another approach was discussed by D. Piomelli (University of California, Irvine). URB 597, an inhibitor of fatty acid amide hydrolase (FAAH), is expected to increase anandamide signaling and is being currently clinically tested in the therapy of pain. An increase in anandamide signaling may also be useful in the therapy of depression. This is a novel approach to the development of antidepressants. The signaling can be enhanced by blocking anadamide metabolism or by...

Z. Khachaturian, PhD. - New approaches to the therapy of Alzheimer’s disease (AD) are discussed in video interviews of this series. According to Z. Khachaturian (Potomac, MD) substantial progress has been made during the last 10 years in our understanding of pathogenesis of Alzheimer’s disease as well as in the discovery of biomarkers and therapeutic approaches. In addition to cholinergic drugs, inhibitors of plaque formation have been discovered, but the currently available...

Wafaa El-Sadr is an Infectious Disease Physician introducing multi-pronged treatment strategies for some of the most pressing pandemics of our time – HIV/AIDS and TB – diseases that often afflict people with the least access to quality health care. MacArthur Fellowships offer the opportunity for Fellows to accelerate their current activities or take their work in new directions. The unusual level of independence afforded to Fellows underscores the spirit of freedom...

"Cytotoxic T cell infusion therapy" 6th International Conference on HHV-6 & 7 in Baltimore, Maryland, USA Day 2 - June 21, 2008 - Treatment Session

"Resistance of HHV-6 to antivirals" 6th International Conference on HHV-6 & 7 in Baltimore, Maryland, USA Day 2 - June 21, 2008 - Treatment Session

"Antiviral activity and metabolic pathway of the new cidofovir analogue 1-(s)-[3-hydroxy-2-phosphonomethoxy)propyl]-5-azacytosine" 6th International Conference on HHV-6 & 7 in Baltimore, Maryland, USA Day 2 - June 21, 2008 - Treatment Session

"Sensitivity of HHV-6 and other human herpesviruses towards the pluripotent drug Artesunate" 6th International Conference on HHV-6 & 7 in Baltimore, Maryland, USA Day 2 - June 21, 2008 - Treatment Session